RW

Richard De Wijn

PB Pamgene B.V.: 4 patents #2 of 29Top 7%
ER Erasmus University Medical Center Rotterdam: 1 patents #63 of 114Top 60%
OH Oslo University Hospital Hf: 1 patents #47 of 65Top 75%
📍 Nijmegen, NL: #168 of 900 inventorsTop 20%
Overall (All Time): #1,134,741 of 4,157,543Top 30%
4
Patents All Time

Issued Patents All Time

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
11802315 Method for predicting the response of non-small-cell lung carcinoma patients to a medicament Robby Ruijtenbeek, Dirgje Maria Adriana Van Den Heuvel, Joan Gertrudis Jacobus Victor Aerts, Adrianus Henricus Josephus Mathijssen 2023-10-31
8962267 Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapy Robby Ruijtenbeek, Maria Helena Hilhorst, Michael Maria Van Den Heuvel, Houke Marian Klomp 2015-02-24
8962268 Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC) Robby Ruijtenbeek, Maria Helena Hilhorst 2015-02-24
8617836 Method for predicting the response of locally advanced rectal cancer to chemoradiotherapy Pieter Jacob Boender, Anne Hansen Ree, Sigurd Folkvord, Kjersti Flatmark, Robby Ruijtenbeek 2013-12-31